» Articles » PMID: 33479413

Alpha-Klotho is a Novel Predictor of Treatment Responsiveness in Patients with Heart Failure

Overview
Journal Sci Rep
Specialty Science
Date 2021 Jan 22
PMID 33479413
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Heart failure is a major cause of death with an increasing population of elderly individuals. Several studies have demonstrated the involvement of soluble alpha-Klotho (sαKl) in various diseases. However, the correlation between sαKl and heart failure remains to be understood. The aim of this study is to investigate the levels and role of sαKl in patients with heart failure. Twenty-eight consecutive patients with acute heart failure (19 male, 9 female), admitted to the Osaka University Hospital from 2010 to 2018, were enrolled in this study. Mean NYHA score, left ventricular ejection fraction and BNP were 3.3, 17.0% and 588 pg/mL, respectively. SαKl significantly increased in heart failure patients. SαKl on admission were significantly higher in patients with heart failure who showed improvement after intensive treatment than that in patients who did not show improvement after the treatment. SαKl levels decreased significantly in patients who showed improvement. Interestingly, sαKl levels increased in male patients with heart failure, but not in female patients. Our data suggest that soluble αKl may be a novel biomarker for the responsiveness against treatment in patients with heart failure with reduced ejection fraction. Our findings may help developing a personalized therapy for different patients with heart failure.

Citing Articles

Use of FGF-23 and sαKlotho for Risk Stratification in Patients with Acute Heart Failure.

Plonka J, Olejnik A, Klus A, Gawrylak-Dryja E, Wezyk N, Rzepiela L J Clin Med. 2025; 14(3).

PMID: 39941530 PMC: 11818865. DOI: 10.3390/jcm14030860.


Activity of Various Cathepsin Proteases and Enrichment of Klotho Protein in the Urine and Urinary Extracellular Vesicles After SARS-CoV-2 Infection.

Bala N, Rafay R, Glover S, Alli A Viruses. 2025; 17(1).

PMID: 39861814 PMC: 11768607. DOI: 10.3390/v17010025.


Serum Klotho Is Elevated in Patients with Acute Myocardial Infarction and Could Predict Poor In-Hospital Prognosis.

Pei Y, Huang W, Cao L, Yang F, Chi C, Zhu J J Cardiovasc Dev Dis. 2024; 11(9).

PMID: 39330350 PMC: 11432139. DOI: 10.3390/jcdd11090292.


Interplay between Senescence and Macrophages in Diabetic Cardiomyopathy: A Review of the Potential Role of GDF-15 and Klotho.

Almohaimeed G, Alonazi A, Bin Dayel A, Alshammari T, Alghibiwi H, Alamin M Biomedicines. 2024; 12(4).

PMID: 38672115 PMC: 11048311. DOI: 10.3390/biomedicines12040759.


Patients with central serous chorioretinopathy have high circulating alpha-klotho concentrations.

Tahara E, Yamamoto Y, Sugisawa T, Gomi F PLoS One. 2023; 18(12):e0295795.

PMID: 38127892 PMC: 10734912. DOI: 10.1371/journal.pone.0295795.


References
1.
Semba R, Cappola A, Sun K, Bandinelli S, Dalal M, Crasto C . Plasma klotho and cardiovascular disease in adults. J Am Geriatr Soc. 2011; 59(9):1596-601. PMC: 3486641. DOI: 10.1111/j.1532-5415.2011.03558.x. View

2.
Nie F, Wu D, Du H, Yang X, Yang M, Pang X . Serum klotho protein levels and their correlations with the progression of type 2 diabetes mellitus. J Diabetes Complications. 2016; 31(3):594-598. DOI: 10.1016/j.jdiacomp.2016.11.008. View

3.
Hirota H, Izumi M, Hamaguchi T, Sugiyama S, Murakami E, Kunisada K . Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failure. Heart Vessels. 2004; 19(5):237-41. DOI: 10.1007/s00380-004-0770-z. View

4.
Nakanishi K, Nishida M, Yamamoto R, Koseki M, Moriyama T, Yamauchi-Takihara K . An implication of Klotho-related molecules in different smoking-related health outcomes between men and women. Clin Chim Acta. 2017; 476:44-48. DOI: 10.1016/j.cca.2017.11.007. View

5.
Mann D, McMurray J, Packer M, Swedberg K, Borer J, Colucci W . Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation. 2004; 109(13):1594-602. DOI: 10.1161/01.CIR.0000124490.27666.B2. View